Bausch Health to reduce debt by $900M using cash on hand

Bausch Health (BHC) Companies announced that its subsidiary, Bausch Health Americas, has issued an irrevocable notice of redemption pursuant to which it will redeem approximately $602M of aggregate principal amount of its outstanding 9.25% Senior Notes due 2026, CUSIP Nos. 91911XAV6 and U9098VAN2, using cash on hand. The redemption date is August 28, 2025. The notice of redemption has been issued to the record holders of such Notes. Nothing contained herein shall constitute a notice of redemption of the Notes. Payment of the redemption price and surrender of the Notes for redemption will be made through the facilities of the Depository Trust Company in accordance with the applicable procedures of the Depository Trust Company. In addition, the Company announced that its subsidiary, Bausch Receivables Funding LP, has given notice to the administrative agent under its Credit and Security Agreement, dated as of June 30, 2023, as amended, of its intention to repay all outstanding amounts in respect of the receivables financing facility thereunder, and to terminate the Receivables Facility and the related agreements as of October 27, 2025. As of July 28, 2025, the aggregate principal amount outstanding under the Receivables Facility was $300M. These measures are consistent with the Company’s focus on optimizing its capital structure.